 | Up a level |
Amante, Romain J; Jehanno, Charly; De Silva, Duvini; Coissieux, Marie-May; Ackerknecht, Markus; Romanet, Vincent; Sethi, Atul; Hamelin, Baptiste; Preca, Bogdan-Tiberius; Piscuoglio, Salvatore; Ng, Charlotte K Y; Mohseni, Morvarid; Bentires-Alj, Mohamed (2023). PI3K inhibition circumvents resistance to SHP2 blockade in metastatic triple-negative breast cancer. Journal of mammary gland biology and neoplasia, 28(1), p. 13. Springer 10.1007/s10911-023-09539-9
Grisouard, Jean; Li, Sai; Kubovcakova, Lucia; Rao, Tata Nageswara; Meyer, Sara C; Lundberg, Pontus; Hao-Shen, Hui; Romanet, Vincent; Murakami, Masato; Radimerski, Thomas; Dirnhofer, Stephan; Skoda, Radek C (2016). JAK2 exon 12 mutant mice display isolated erythrocytosis and changes in iron metabolism favoring increased erythropoiesis. Blood, 128(6), pp. 839-851. American Society of Hematology 10.1182/blood-2015-12-689216
Meyer, Sara C; Keller, Matthew D; Chiu, Sophia; Koppikar, Priya; Guryanova, Olga A; Rapaport, Franck; Xu, Ke; Manova, Katia; Pankov, Dmitry; O'Reilly, Richard J; Kleppe, Maria; McKenney, Anna Sophia; Shih, Alan H; Shank, Kaitlyn; Ahn, Jihae; Papalexi, Eftymia; Spitzer, Barbara; Socci, Nick; Viale, Agnes; Mandon, Emeline; ... (2015). CHZ868, a Type II JAK2 Inhibitor, Reverses Type I JAK Inhibitor Persistence and Demonstrates Efficacy in Myeloproliferative Neoplasms. Cancer cell, 28(1), pp. 15-28. Cell Press 10.1016/j.ccell.2015.06.006
